SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 47 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $800 | -100.0% | 428,000 | -84.5% | 0.00% | -100.0% |
| Q3 2022 | $4,638,000 | +15.1% | 2,761,000 | -13.4% | 0.01% | +150.0% |
| Q2 2022 | $4,028,000 | -9.2% | 3,187,000 | -5.6% | 0.00% | -33.3% |
| Q1 2022 | $4,434,000 | -59.1% | 3,376,000 | -54.9% | 0.00% | +50.0% |
| Q4 2021 | $10,838,000 | +173.7% | 7,480,000 | +181.3% | 0.00% | 0.0% |
| Q3 2021 | $3,960,000 | +10.6% | 2,659,000 | -1.2% | 0.00% | 0.0% |
| Q2 2021 | $3,579,000 | -23.5% | 2,691,000 | -24.8% | 0.00% | -33.3% |
| Q1 2021 | $4,677,000 | +426.1% | 3,580,000 | +517.2% | 0.00% | +200.0% |
| Q1 2020 | $889,000 | -17.0% | 580,000 | +5.3% | 0.00% | 0.0% |
| Q4 2019 | $1,071,000 | +157.5% | 551,000 | +74.9% | 0.00% | – |
| Q3 2019 | $416,000 | +462.2% | 315,000 | +826.5% | 0.00% | – |
| Q2 2019 | $74,000 | -79.8% | 34,000 | -83.3% | 0.00% | – |
| Q1 2019 | $366,000 | – | 203,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 8,907,000 | $17,329,459 | 1.40% |
| CSS LLC/IL | 7,106,000 | $13,798,218 | 0.91% |
| Aequim Alternative Investments LP | 5,000,000 | $9,672,055 | 0.31% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,948,000 | $11,571,045 | 0.23% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,051,000 | $3,989,195 | 0.11% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,080,000 | $13,695,632 | 0.07% |
| Point72 Asset Management, L.P. | 9,007,000 | $17,447,371 | 0.05% |
| SSI INVESTMENT MANAGEMENT LLC | 257,000 | $496,500 | 0.04% |
| LORD, ABBETT & CO. LLC | 3,097,000 | $5,983 | 0.02% |
| D. E. Shaw & Co., Inc. | 4,100,000 | $7,953,192 | 0.01% |